Commissioner’s § 481.034(g) Objections Are Effectively Unreviewable and Not Subject to APA Rulemaking; Courts May Not Enjoin Agencies to “Rewrite” Controlled-Substance Schedules

1. Introduction

In Texas Department of State Health Services and Dr. Jennifer A. Shuford, in Her Official Capacity as Commissioner of the Texas Department of State Health Services v. Sky Marketing Corp., d/b/a Hometown Hero; Create a Cig Temple, LLC; Darrell Surif; and David Walden (May 1, 2026), the Supreme Court of Texas confronted a high-profile dispute over whether Texas law permits manufactured delta-8 THC products sold as “consumable hemp products.”

After the 2019 Texas Farm Bill excluded “hemp” and “the [THC] in hemp” from the Texas Controlled Substances Act’s schedules, the Commissioner declined to adopt a federal DEA change and then amended Texas Schedule I definitions for “Tetrahydrocannabinols” and “Marihuana extract” in 2021. The Department later posted a website statement asserting that “Delta-8 in any concentration” is a Schedule I controlled substance.

A coalition of hemp businesses and consumers (the “vendors”) sued, alleging (i) the Commissioner acted ultra vires by using the wrong scheduling procedures and by contradicting the 2019 Texas Farm Bill, and (ii) the Department’s website statement was an invalid APA “rule.” The trial court granted a temporary injunction (including an order compelling removal of the challenged schedule language), and the court of appeals affirmed.

The Texas Supreme Court held the vendors had standing and the dispute was ripe, but otherwise reversed: sovereign immunity barred the ultra vires and APA claims, and the temporary injunction could not stand.

2. Summary of the Opinion

  • Standing and ripeness affirmed: A licensed hemp business plausibly alleged concrete, traceable, and redressable economic and reputational injury from compelled compliance with a coercive licensing regime.
  • Ultra vires claims rejected (sovereign immunity applies): The Commissioner acted within her statutory authority under Tex. Health & Safety Code § 481.034(g) when objecting to the federal change and then clarifying Texas schedules consistent with that objection; courts may not second-guess the merits of a § 481.034(g) objection that is “final unless altered by statute.”
  • No substantive conflict shown sufficient for ultra vires relief: The Court rejected the argument that the 2019 Texas Farm Bill unmistakably legalized potent, manufactured delta-8 THC; the statutory structure and history preserve broad executive scheduling discretion absent a clear legislative withdrawal.
  • APA claim rejected (sovereign immunity applies): The Department’s website statement was not an APA “rule,” and in any event the Texas Controlled Substances Act provides the controlling procedural scheme for scheduling; the statement had no independent legal effect and was disclaimed as enforceable.
  • Temporary injunction reversed: With immunity intact, the injunction fell; the Court also cautioned against injunctions that (i) effectively order executive officials to rewrite the law/schedules and (ii) extend relief beyond the parties (“universal” injunction concerns).

3. Analysis

3.1. Precedents Cited

A. Standing, injury, traceability, and redressability

  • Bost v. Ill. State Bd. of Elections: Quoted for the “personal stake” and “What’s it to you?” framing of standing, emphasizing separation-of-powers limits on who may invoke judicial power. The Court used it to reinforce that the vendors had to show individualized injury, not generalized disagreement with policy.
  • Heckman v. Williamson County and Abbott v. Mex. Am. Legis. Caucus: Supplied the Texas standing elements—injury in fact, traceability, and redressability—and the requirement that injury be concrete, particularized, and actual or imminent.
  • DaimlerChrysler Corp. v. Inman: Cited through Heckman for the “actual or imminent, not hypothetical” requirement, helping distinguish real compliance injuries from speculative fears.
  • Mosaic Baybrook One, L.P. v. Simien and Czyzewski v. Jevic Holding Corp.: Used to confirm that even small monetary losses can constitute an injury in fact.
  • Lexmark Int'l, Inc. v. Static Control Components, Inc.: Supported the proposition that lost sales and reputational harm are classic standing injuries.
  • Diamond Alt. Energy, LLC v. EPA: Provided the “object of regulation” principle—when the plaintiff is regulated, causation and redressability are ordinarily straightforward. The Court analogized the schedules’ market-targeting effect to the challenged regulation in Diamond Alt.
  • Simon v. E. Ky. Welfare Rights Org. and Lujan v. Defs. of Wildlife: Anchored the traceability standard, requiring a causal connection not dependent on independent third-party actions.
  • State v. Zurawski: Distinguished situations where an injunction would be an “empty vessel” because the defendant lacks enforcement authority. The Court relied on Zurawski to hold redressability existed here due to DSHS’s civil-licensing enforcement powers—even if it cannot prosecute criminally.
  • In re Abbott (2020): Used to show that standing can fail if the State disclaims enforcement intent; here, no comparable civil-enforcement disclaimer was made.
  • Miga v. Jensen: Invoked by analogy to distinguish “voluntary” compliance from compliance compelled by governmental coercion—important to treating pre-enforcement economic losses as traceable to state action.

B. Ripeness and advisory-opinion avoidance

  • Waco ISD v. Gibson, Patterson v. Planned Parenthood of Houston & Se. Tex., Inc., and Sw. Elec. Power Co. v. Lynch: Provided the ripeness framework requiring sufficiently developed facts and a likely, non-contingent injury.
  • Tex. Dep't of Fam. & Protective Servs. v. Grassroots Leadership, Inc.: Emphasized that deciding unripe disputes produces impermissible advisory opinions under Texas’s constitutional limits.
  • Lujan v. Nat'l Wildlife Fed'n and Abbott Labs. v. Gardner: Supported justiciability of pre-enforcement challenges when regulated parties must immediately change business practices to avoid strong sanctions. The Court analogized the hemp licensing context to the “practical compulsion” described in these cases.

C. Ultra vires, sovereign immunity, and finality provisions

  • Chambers-Liberty Counties Navigation Dist. v. State: Supplied the core test: an ultra vires plaintiff must show the official acted beyond lawful authority; courts then evaluate conflict with state law within the limited interlocutory record.
  • Willacy County Appraisal Dist. v. Sebastian Cotton & Grain, Ltd.: Central to the Court’s reasoning on “finality” clauses. The Court used it to explain that when a statute makes an executive determination “final,” it broadens executive discretion and narrows judicial review—supporting the conclusion that the merits of a § 481.034(g) objection are not for courts.
  • Cities of Austin, Dallas, Fort Worth & Hereford v. Sw. Bell Tel. Co.: Reinforced whole-statute interpretation and avoiding isolated readings—key to rejecting the vendors’ hemp-text argument as insufficiently contextual.
  • Whitman v. Am. Trucking Ass'ns: Supplied the “elephants in mouseholes” canon. The Court applied it to reject the claim that the legislature implicitly legalized potent manufactured THC through hemp definitional language focused on the plant and delta-9 concentration.

D. APA “rules” and specialized statutory schemes

  • PUC v. RWE Renewables Ams., LLC: Provided the principle that where the legislature has established a well-developed, specific regulatory scheme, APA procedures do not govern the agency action at issue. This was the backbone for holding the Texas Controlled Substances Act—not the APA—governs scheduling publications and related statements.
  • TEA v. Leeper: Cited for the proposition that not every agency statement is an APA “rule.”
  • El Paso Hosp. Dist. v. Tex. Health & Hum. Servs. Comm'n: Used to distinguish true APA rules (which carry “effect of law”) from nonbinding informational statements.

E. Equitable limits, separation of powers, and broad injunctions

  • Whole Woman's Health v. Jackson: Cited for the equitable principle that courts do not “enjoin the world at large” or “laws themselves,” supporting the Court’s criticism of an injunction that effectively orders executive rewriting of schedules.
  • Trump v. CASA, Inc.: Quoted for skepticism toward “universal injunctions” that exceed traditional equitable authority, used as persuasive guidance for Texas courts.
  • In re Abbott (2022): Invoked to caution against granting relief to nonparties; the Court warned Texas courts to confine injunctions to what is necessary to protect parties’ rights.

3.2. Legal Reasoning

A. Why standing and ripeness existed despite no criminal-enforcement power

The Department argued the vendors’ injury was really fear of criminal prosecution and therefore not redressable by an injunction against DSHS (a civil regulator). The Court rejected that narrowing move by focusing on civil licensing consequences: DSHS can revoke or refuse licenses for Controlled Substances Act violations, and licensed businesses operate “under the shadow” of that authority.

Critically, the Court treated the vendors’ compliance as coerced, not voluntary: in a tightly regulated industry, changing conduct to avoid license loss is a practical compulsion. That coercion transformed the vendors’ revenue loss into a concrete, present injury that was traceable to the challenged schedules and redressable through injunctive relief.

B. The core holding on § 481.034(g): discretion + finality constrains judicial review

The opinion’s center of gravity is structural: the Texas Controlled Substances Act assigns the Commissioner “primary responsibility” over civil schedules and does so with an “unusual degree of discretion.” Section 481.034(g) creates an automatic-incorporation model for federal scheduling actions, subject to a Commissioner objection.

Two features mattered most:

  1. Trigger and procedure: The DEA’s interim final rule “amend[ed] the scope” of “marihuana extract” and “decontrolled” certain hemp-derived extracts; the Commissioner treated that as a qualifying federal change, objected, published reasons, provided an opportunity to be heard, and published a final decision. That satisfied § 481.034(g), so the more elaborate procedures in §§ 481.034(b), (d), (e) and § 481.035 did not apply.
  2. Finality: The Commissioner’s § 481.034(g) decision is “final unless altered by statute.” Drawing from Willacy County Appraisal Dist. v. Sebastian Cotton & Grain, Ltd., the Court treated this as a legislative allocation of corrective authority to the legislature, not to courts. Courts can assess whether the Commissioner acted within the statutory lane, but they cannot second-guess the merits of a properly issued objection.

C. Substantive interpretation: hemp text does not clearly legalize potent manufactured delta-8 THC

The vendors advanced a strong text-based argument: because “hemp” is defined by a delta-9 concentration cap, and the Act excludes “hemp” and “the [THC] in hemp” from controlled-substance status, delta-8 derived from hemp inputs should be lawful so long as delta-9 remains ≤ 0.3%.

The Court acknowledged the argument’s force but rejected it as the “most natural interpretation” in context. The reasoning had several steps:

  • Whole-statute structure: The schedules are designed to be dynamically managed by the Commissioner; courts should not infer a major withdrawal of that discretion without clear legislative statement.
  • Clear-statement expectation in drug policy: The Court stressed that legalization of “powerful drugs” is a major social-policy change that the legislature would do unmistakably, not indirectly through definitional language.
  • “Elephants in mouseholes”: Treating “all derivatives” of hemp as encompassing lab-created, high-potency psychoactive products would be an elephant hidden in a mousehole—especially where the claimed product emulates marijuana’s “high.”
  • Natural-plant focus: The hemp definition was read as oriented to the plant and naturally occurring constituents (with a delta-9 cap), not as a blanket permission for manufacturing concentrated intoxicants merely because a starting input comes from hemp.

The Court also discussed a narrow theoretical tension: delta-8 exists in trace natural amounts in hemp, and the statute excludes “the [THC] in hemp,” yet the 2021 schedule text exempted only delta-9 up to 0.3%. But the Commissioner represented she would tolerate naturally occurring trace delta-8 (and the Court emphasized practical detectability realities). Importantly, that concession did not help the vendors because their products contain concentrations far beyond what naturally occurs in any plant.

D. The APA claim fails: specialized scheduling scheme + no independent legal effect

The vendors characterized the Department’s website statement (“Delta-8 in any concentration” is Schedule I) as an APA “rule” adopted without notice-and-comment procedures. The Court rejected this on two overlapping grounds:

  • Governing procedure is not the APA: Under PUC v. RWE Renewables Ams., LLC, where a specific statutory scheme governs, the APA does not overlay additional procedural requirements. Here, the Texas Controlled Substances Act—especially § 481.034—governs how schedules are modified and published.
  • A summary is not a rule: The website statement purported to summarize the schedules and had no independent enforceable legal effect (and the Department disclaimed any intent to enforce it). Under TEA v. Leeper and El Paso Hosp. Dist. v. Tex. Health & Hum. Servs. Comm'n, not every agency pronouncement is a “rule.”

E. Limits on injunctive relief: no rewriting schedules; caution against universal relief

Although the Court reversed on immunity grounds, it flagged two separation-of-powers issues:

  • Anti-“writ of erasure” concern: The trial court’s injunction ordered the Department to remove schedule language and prevent future publications—functionally directing executive policymakers to rewrite the schedules, not merely restraining enforcement as to parties. Citing Whole Woman's Health v. Jackson, the Court emphasized courts cannot enjoin “laws themselves” or “the world at large.”
  • Universal injunction skepticism: The injunction purported to protect nonparties statewide. The Court cited Trump v. CASA, Inc. and reiterated, through In re Abbott (2022), that Texas courts should ensure injunctions are no broader than necessary to protect parties before them.

3.3. Impact

A. Reinforced executive primacy in Texas civil drug scheduling

The opinion strongly fortifies the Commissioner’s scheduling authority—especially when acting through § 481.034(g). The Court reads “final unless altered by statute” as a meaningful reallocation of institutional competence: courts are not the venue for second-guessing the merits of the Commissioner’s objection to federal scheduling actions.

B. Clear pathway for regulated businesses to establish standing—without “betting the farm”

The Court’s standing/ripeness analysis is consequential for pre-enforcement challenges in heavily licensed industries. It recognizes that coercive licensing regimes can create immediate economic injury from compelled compliance, establishing traceability and redressability even where criminal enforcement is not directly at issue.

C. APA containment: informational statements about schedules are unlikely to be “rules”

Agencies’ web guidance and summaries—when nonbinding and not independently enforceable—will be harder to attack as APA rules, particularly where a separate statute supplies the governing procedural framework.

D. Injunction discipline in public-law litigation

While not dispositive, the Court’s cautions signal skepticism toward injunctions that (i) compel changes to legal texts and publications, and/or (ii) extend relief beyond the parties. Litigants should expect closer tailoring requirements and heightened attention to separation-of-powers boundaries.

4. Complex Concepts Simplified

Controlled-substance “schedules” (I–V)
Lists that classify drugs by perceived medical use and abuse potential. Schedule I is the most restricted category. In Texas, the Commissioner is statutorily assigned primary responsibility for the civil schedules.
§ 481.034(g) “automatic incorporation” + objection
When federal law changes the status of a substance, Texas generally follows automatically—unless the Commissioner objects within a set period. If the Commissioner objects, she must publish reasons, allow interested parties to be heard, and issue a decision that is “final unless altered by statute.”
Ultra vires claim
A narrow lawsuit alleging an official acted beyond legal authority. It is one of the limited routes around sovereign immunity, but it requires showing a clear conflict with statutory authority—not merely that the official’s decision was wrong.
Sovereign immunity
The State and its agencies generally cannot be sued without legislative permission. If an ultra vires claim fails (because the official stayed within delegated authority), immunity blocks the suit.
Standing and ripeness
Standing asks whether the plaintiff is the right party (injured in a concrete, traceable, redressable way). Ripeness asks whether the dispute is ready now (injury has occurred or is likely soon, not speculative).
APA “rule”
A binding agency statement of general applicability with the effect of law, typically adopted through notice-and-comment. Nonbinding guidance that merely summarizes existing law is less likely to qualify.
“Universal injunction”
An injunction that protects people not in the lawsuit. Courts increasingly question whether such relief exceeds traditional equitable limits.

5. Conclusion

This decision draws a sharp institutional boundary in Texas controlled-substance scheduling disputes: regulated parties may have standing to sue when licensing coercion produces immediate economic harm, but courts cannot use ultra vires doctrine or the APA to override a Commissioner’s § 481.034(g) objection and related schedule clarifications, where the legislature has declared the decision “final unless altered by statute.”

The ruling thereby channels disputes over emerging cannabinoids—especially manufactured, high-potency delta-8 THC—toward legislative resolution, reinforces that the Texas Controlled Substances Act (not the APA) governs schedule-setting processes, and cautions trial courts against injunctions that functionally rewrite the schedules or extend protection beyond the litigants.